WHY IT MATTERS: If Medicare moves forward with covering specific cannabis medications, seniors on fixed incomes could access cannabinoid-based treatments for pain, sleep, and other age-related conditions without bearing the full cost themselves. CLINICAL OVERVIEW: Medicare coverage of cannabis-based medications represents a significant shift in how federal health policy may approach cannabinoid therapeutics for older adults. Seniors represent a growing demographic of cannabis users, driven largely by chronic pain, sleep disturbance, and neuropathic conditions that are common in aging populations.